Claus-Steffen Sturzebecher

This inventor holds 8 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1989-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claus-Steffen Sturzebecher. Retrieved from https://idiyas.com/inventor/claus-steffen-sturzebecher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

8 out of 1,409

Schering Aktiengesellschaft

patents

Years Active: 1989-1994

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5374654 - 9-substituted carbacyclin derivatives, processes for their preparation, (1994-12-20),

2. 5190964 - 5-fluorocarbacyclins, their preparation and pharmaceutical use (1993-03-02),

3. 5104861 - 7-oxoprostacyclin derivatives which are useful as pharmaceuticals (1992-04-14),

4. 5093325 - Combination preparation having antithrombotic action (1992-03-03),

5. 5053400 - Novel 9-substituted carbacyclin derivatives, processes for their (1991-10-01),

6. 5023273 - 6-oxoprostaglandin E derivatives, process for their production and their (1991-06-11),

7. 4983629 - 11-haloprostane derivatives, processes for their preparation and their (1991-01-08),

8. 4870104 - 11-haloprostane derivatives, processes for their preparation and their (1989-09-26),

Title: The Innovations of Claus-Steffen Sturzebecher

Introduction

Claus-Steffen Sturzebecher is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on carbacyclin derivatives. With a total of eight patents to his name, Sturzebecher has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Sturzebecher has developed 9-substituted carbacyclin derivatives and processes for their preparation. His inventions include carbacyclin derivatives of Formula I, which feature various substituents defined in his patents. Notably, he has worked on 5-fluorocarbacyclin derivatives, which are significant for their pharmaceutical applications.

Career Highlights

Sturzebecher's career has been marked by his dedication to research and innovation. He has been associated with Schering Aktiengesellschaft, a company known for its focus on pharmaceuticals and healthcare. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Throughout his career, Sturzebecher has collaborated with notable colleagues, including Helmut Vorbruggen and Werner Skuballa. These collaborations have further enhanced his research and innovation efforts in the pharmaceutical field.

Conclusion

Claus-Steffen Sturzebecher's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic options.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]